FindTrial
Sign In

SCMC-ALL-2005 Protocol

The Combined Chemotherapy Protocol of SCMC-ALL-2005 for Pediatric Acute Lymphoblastic Leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-14005003
Enrollment
Unknown
Registered
2014-07-21
Start date
2005-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Acute Lymphoblastic Leukemia

Interventions

MRD positive group:MRD directed interventional treatment

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. New ALL, age younger than 18y

Exclusion criteria

Exclusion criteria: 1. Mature B-ALL; 2. Very High Risk group, include Ph+ ALL and induction failure.

Design outcomes

Primary

MeasureTime frame
Minimal Residual Disease;—

Countries

China

Contacts

Public ContactTang Jingyan
tangjingyan@scmc.com.cn+86 021-38626161-82076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026